Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden — Papers | ScholarIQ

Scholar IQ

Help

Try ScholarIQ free

Upload Records Snowball Search Search OpenAlex

About the database

ScholarIQanswers from OpenAlex

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

PaperCitations, authors & open-access status

3,149

Citations

2,018

Year

bronze

OA Status

IDs:DOI PMID OpenAlex

Related on ScholarIQ

Matthew D. Hellmann

Adam Płużański

Julie R. Brahmer

Luis Paz‐Ares

New England Journal of Medicine